SELP and breast cancer: We obtained 19.4% of CD62P-positive platelets (95%CI: 10.4-38.6) in HD and 18.1% (95%CI: 5.6-48.7) in breast cancer patients and thus similar platelet activation levels in both groups (p = 0.82, Figure 3D).